- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 4 x XM5: 6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one(Non-covalent)
XM5.2: 10 residues within 4Å:- Chain A: W.106, G.150, G.151, M.155, N.162
- Chain B: F.127, I.129, F.179
- Ligands: XM5.3, FAD.5
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:N.162
- Hydrophobic interactions: B:F.127, B:I.129
XM5.3: 12 residues within 4Å:- Chain A: W.106, F.107, G.150, G.151, Y.156, N.162
- Chain B: F.127, I.129, G.175, F.179
- Ligands: XM5.2, FAD.5
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:N.162
- Hydrophobic interactions: B:F.127, B:F.179, B:F.179
XM5.4: 12 residues within 4Å:- Chain A: F.127, I.129, G.175, F.179
- Chain B: W.106, F.107, G.150, G.151, M.155, N.162
- Ligands: XM5.7, FAD.8
4 PLIP interactions:1 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:N.162
- Hydrophobic interactions: A:F.127, A:F.179, A:F.179
XM5.7: 10 residues within 4Å:- Chain A: F.127, I.129, F.179
- Chain B: W.106, G.150, G.151, M.155, N.162
- Ligands: XM5.4, FAD.8
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:N.162
- Hydrophobic interactions: A:F.127, A:I.129
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.5: 27 residues within 4Å:- Chain A: H.12, K.16, S.17, F.18, N.19, S.21, P.103, L.104, Y.105, W.106, F.107, T.148, T.149, G.150, G.151, Y.156, P.193, E.194, R.201, K.202, V.205
- Chain B: N.67, Y.68, G.69, D.118
- Ligands: XM5.2, XM5.3
22 PLIP interactions:20 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:Y.105, A:Y.105, A:Y.105, A:Y.105, B:Y.68
- Hydrogen bonds: A:F.18, A:N.19, A:N.19, A:S.21, A:S.21, A:L.104, A:L.104, A:W.106, A:F.107, A:T.148, A:T.148, A:G.150, A:G.151, A:Y.156, A:R.201, B:N.67
- Salt bridges: A:H.12
FAD.8: 26 residues within 4Å:- Chain A: N.67, Y.68, G.69, D.118
- Chain B: H.12, K.16, S.17, F.18, N.19, S.21, P.103, L.104, Y.105, W.106, F.107, T.148, T.149, G.150, G.151, Y.156, P.193, E.194, R.201, V.205
- Ligands: XM5.4, XM5.7
22 PLIP interactions:20 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:Y.105, B:Y.105, B:Y.105, A:Y.68
- Hydrogen bonds: B:F.18, B:N.19, B:N.19, B:S.21, B:S.21, B:W.106, B:F.107, B:T.148, B:T.148, B:G.150, B:G.151, B:Y.156, B:Y.156, B:E.194, A:N.67
- Water bridges: B:K.16
- Salt bridges: B:H.12
- pi-Stacking: B:Y.105
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Maiti, A. et al., Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities. J.Med.Chem. (2009)
- Release Date
- 2009-03-24
- Peptides
- Ribosyldihydronicotinamide dehydrogenase [quinone]: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 4 x XM5: 6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Maiti, A. et al., Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities. J.Med.Chem. (2009)
- Release Date
- 2009-03-24
- Peptides
- Ribosyldihydronicotinamide dehydrogenase [quinone]: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B